Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	271.91M +59.7%
Revenue (ttm)	114.96M +42.9%
Net Income	20.48M +55.5%
EPS	0.04 +55.5%
Shares Out	581.33M
PE Ratio	13.20
Forward PE	14.34
Dividend	0.01 (2.72%)
Ex-Dividend Date	Sep 11, 2025

Volume	101,629
Average Volume	162,458
Open	0.6550
Previous Close	0.6250
Day's Range	0.6000 - 0.6550
52-Week Range	0.3050 - 0.8300
Beta	0.28
RSI	44.26
Earnings Date	Apr 8, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP